Half-year report · HY
190A.TEDINET S100XYSP
Period2025-09-01 → 2026-02-28
Filed2026-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 42
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥663m | 2025-09-01 → 2026-02-28 | Standalone | Operating income |
| Operating income | −¥996m | 2024-09-01 → 2025-02-28 | Standalone | Operating income |
| Ordinary income | −¥633m | 2025-09-01 → 2026-02-28 | Standalone | Ordinary income |
| Ordinary income | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Ordinary income |
| Profit before tax | −¥633m | 2025-09-01 → 2026-02-28 | Standalone | Income before income taxes |
| Profit before tax | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Income before income taxes |
| Net income | −¥634m | 2025-09-01 → 2026-02-28 | Standalone | Profit loss |
| Net income | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥976m | 2024-09-01 → 2025-02-28 | Standalone | Profit loss |
| Total assets | ¥2.5bn | at 2026-02-28 | Standalone | Assets |
| Total assets | ¥2.7bn | at 2025-08-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2025-02-28 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥197m | at 2026-02-28 | Standalone | Liabilities |
| Total liabilities | ¥244m | at 2025-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.3bn | at 2026-02-28 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2025-08-31 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2025-02-28 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2025-08-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.4bn | at 2026-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2025-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2024-08-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥611m | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥53,000 | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥5m | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥667,000 | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥510m | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-8.95 | 2025-09-01 → 2026-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-26.03 | 2024-09-01 → 2025-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.31 | 2024-09-01 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.8% | at 2026-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2025-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.0% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 73,730,900 | at 2026-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,988,800 | at 2025-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,988,800 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 334
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf | InterimDuration_NonConsolidatedMember | -2420000 | JPY |
| Net cash provided by used in operating activities | Prior1InterimDuration_NonConsolidatedMember | -1114470000 | JPY |
| Net cash provided by used in operating activities | InterimDuration_NonConsolidatedMember | -611138000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1InterimDuration_NonConsolidatedMember | -667000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration_NonConsolidatedMember | － | JPY |
| Other net inv cf | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Other net inv cf | InterimDuration_NonConsolidatedMember | 53000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration_NonConsolidatedMember | -667000 | JPY |
| Net cash provided by used in investment activities | InterimDuration_NonConsolidatedMember | 53000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1InterimDuration_NonConsolidatedMember | 61580000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | InterimDuration_NonConsolidatedMember | 499500000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | Prior1InterimDuration_NonConsolidatedMember | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | InterimDuration_NonConsolidatedMember | 10388000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration_NonConsolidatedMember | 61580000 | JPY |
| Net cash provided by used in financing activities | InterimDuration_NonConsolidatedMember | 509889000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration_NonConsolidatedMember | -1053557000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration_NonConsolidatedMember | -101195000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 4329624000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2548955000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant_NonConsolidatedMember | 3276066000 | JPY |
| Cash and cash equivalents | InterimInstant_NonConsolidatedMember | 2447760000 | JPY |
| Directors compensations sga | Prior1InterimDuration_NonConsolidatedMember | 22900000 | JPY |
| Directors compensations sga | InterimDuration_NonConsolidatedMember | 24600000 | JPY |
| Payroll and allowances sga | Prior1InterimDuration_NonConsolidatedMember | 28635000 | JPY |
| Payroll and allowances sga | InterimDuration_NonConsolidatedMember | 27105000 | JPY |
| Depreciation sga | Prior1InterimDuration_NonConsolidatedMember | 361000 | JPY |
| Depreciation sga | InterimDuration_NonConsolidatedMember | － | JPY |
| Business consignment expenses sga | Prior1InterimDuration_NonConsolidatedMember | 87623000 | JPY |
| Business consignment expenses sga | InterimDuration_NonConsolidatedMember | 55588000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-04-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第９期中（自2025年９月１日 至2026年２月28日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 | |
| Company name in english cover page | FilingDateInstant | Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 三宅 洋 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の１ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6661-9543 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)コーポレート部長 岡谷 大 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の１ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6661-9543 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)コーポレート部長 岡谷 大 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E38905 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 190A0 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 | |
| Filer name in english | FilingDateInstant | Chordia Therapeutics Inc. | |
| Fund name in japanese | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |